ReviewTargeted oncology2025

Relugolix in Combination with Androgen Receptor Pathway Inhibitors in the Treatment of Metastatic Prostate Cancer: A Clinical Perspective.

Tomas BuchlerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.